Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-002711
Filing Date
2022-01-10
Accepted
2022-01-10 17:02:03
Documents
2
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2235
2 POA DOCUMENT poa.txt EX-24 4324
  Complete submission text file 0001209191-22-002711.txt   8049
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADVERUM BIOTECHNOLOGIES, INC. 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
Seyedkazemi Setareh (Reporting) CIK: 0001903088 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36579 | Film No.: 22521884